summary
Introduced
01/22/2019
01/22/2019
In Committee
01/22/2019
01/22/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
For legislation to provide equal access to medication assisted treatment. Financial Services.
AI Summary
This bill aims to provide equal access to medication-assisted treatment (MAT) for opioid addiction. It requires the Massachusetts Group Insurance Commission, the state Medicaid program (MassHealth), and private health insurers in Massachusetts to cover the costs of three FDA-approved medications for opioid addiction treatment: buprenorphine, injectable naltrexone, and methadone. The bill also limits the out-of-pocket costs that enrollees can be charged for methadone treatment programs to no more than 20% of the total reimbursement paid to the provider. The bill's provisions are intended to improve access to evidence-based treatment for individuals struggling with opioid use disorder in Massachusetts.
Committee Categories
Business and Industry
Sponsors (4)
Last Action
Accompanied a study order, see S2543 (on 02/18/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/S609 |
| Bill | https://malegislature.gov/Bills/191/S609.pdf |
Loading...